Viewing StudyNCT00003412



Ignite Creation Date: 2024-05-05 @ 11:19 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003412
Status: UNKNOWN
Last Update Posted: 2013-09-17
First Post: 1999-11-01

Brief Title: Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
Sponsor: Beth Israel Deaconess Medical Center
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000066424
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Beth Israel Deaconess Medical Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH